Morgan Stanley’s EndoChoice Holdings, Inc. GI Stock Holding History

Morgan Stanley’s Portfolio GI Stock Details GI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,917	Closed	-$31K	–	6665
2016 Q3	$31K	Sell	3,917 -407	-9%	-$1.91K	﹤0.01%	5779
2016 Q2	$21K	Sell	4,324 -7,808	-64%	-$37.2K	﹤0.01%	5843
2016 Q1	$63K	Sell	12,132 -4,018	-25%	-$22K	﹤0.01%	5517
2015 Q4	$135K	Buy	16,150 +9,531	+144%	+$91.6K	﹤0.01%	5263
2015 Q3	$75K	Sell	6,619 -2,027	-23%	-$31.7K	﹤0.01%	5557
2015 Q2	$141K	Buy	+8,646	New	+$144K	﹤0.01%	5412

Morgan Stanley's GI Position: Q4 2016 in Review

Morgan Stanley sold out of EndoChoice Holdings, Inc. (GI) in Q4 2016, closing a stake of 3,917 shares — an estimated $31K sold.

Morgan Stanley first reported a position in GI in Q2 2015 and held it in 6 quarters. The position peaked at $141K in Q2 2015. 0 funds tracked by Wall St. Rank hold GI as of Q4 2016.

Morgan Stanley reported no remaining EndoChoice Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Morgan Stanley sold 3,917 EndoChoice Holdings, Inc. shares in Q4 2016, an estimated $31K.
Morgan Stanley first reported a position in EndoChoice Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Morgan Stanley's EndoChoice Holdings, Inc. position peaked at $141K in Q2 2015.
0 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.